Literature DB >> 27481856

An Optimized Method for Protein Extraction from OCT-Embedded Human Kidney Tissue for Protein Quantification by LC-MS/MS Proteomics.

Marc Vrana1, Anne Goodling1, Maryam Afkarian1, Bhagwat Prasad2.   

Abstract

The existing biobanks of remnant tissue from clinically indicated kidney biopsies are attractive potential reservoirs for quantification of clinically relevant human tissue proteins by quantitative proteomics. However, a significant caveat of this strategy is that the tissues are often preserved in optimal cutting temperature (OCT) medium. Although OCT is an effective method of preserving the morphologic and immunohistological characteristics of tissues for later study, it significantly impacts efforts to quantify protein expression by liquid chromatography-tandem mass spectrometry methods. We report here a simple, reproducible, and cost-effective procedure to extract proteins from OCT-embedded tissue samples. Briefly, the excess frozen OCT medium was scraped before thawing from the tissue specimens stored at -80°C for ∼3 months. The tissue samples were homogenized and diethyl ether/methanol extraction was performed to remove the remaining OCT medium. The recovered protein was denatured, reduced, and alkylated. The second step of protein extraction and desalting was performed by chloroform/methanol/water extraction of denatured proteins. The resultant protein pellet was trypsin-digested and the marker proteins of various kidney cellular compartments were quantified by targeted selective reaction monitoring proteomics. Upon comparison of peptide signals from OCT-embedded tissue and flash-frozen tissue from the same donors, both individual protein quantities, and their interindividual variabilities, were similar. Therefore, the approach reported here can be applied to clinical reservoirs of OCT-preserved kidney tissue to be used for quantitative proteomics studies of clinically relevant proteins expressed in different parts of the kidney (including drug transporters and metabolizing enzymes).
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27481856      PMCID: PMC5034699          DOI: 10.1124/dmd.116.071522

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  24 in total

1.  Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation.

Authors:  Sarah A Schwartz; Michelle L Reyzer; Richard M Caprioli
Journal:  J Mass Spectrom       Date:  2003-07       Impact factor: 1.982

2.  Formalin-fixed paraffin-embedded (FFPE) proteome analysis using gel-free and gel-based proteomics.

Authors:  Omid Azimzadeh; Zarko Barjaktarovic; Michaela Aubele; Julia Calzada-Wack; Hakan Sarioglu; Michael J Atkinson; Soile Tapio
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

3.  New and improved proteomics technologies for understanding complex biological systems: addressing a grand challenge in the life sciences.

Authors:  Leroy E Hood; Gilbert S Omenn; Robert L Moritz; Ruedi Aebersold; Keith R Yamamoto; Michael Amos; Jennie Hunter-Cevera; Laurie Locascio
Journal:  Proteomics       Date:  2012-09       Impact factor: 3.984

4.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

5.  Renal transporters in drug disposition, drug-drug interactions, and nephrotoxicity.

Authors:  Bo Feng; Ayman F El-Kattan; Zaher A Radi
Journal:  Curr Protoc Toxicol       Date:  2012-08

6.  Tissue expression of nephrin in human and pig.

Authors:  Arvi-Matti Kuusniemi; Marjo Kestilä; Jaakko Patrakka; Anne-Tiina Lahdenkari; Vesa Ruotsalainen; Christer Holmberg; Riitta Karikoski; Riitta Salonen; Karl Tryggvason; Hannu Jalanko
Journal:  Pediatr Res       Date:  2004-02-05       Impact factor: 3.756

7.  Urinary proteomics in diabetes and CKD.

Authors:  Kasper Rossing; Harald Mischak; Mohammed Dakna; Petra Zürbig; Jan Novak; Bruce A Julian; David M Good; Joshua J Coon; Lise Tarnow; Peter Rossing
Journal:  J Am Soc Nephrol       Date:  2008-04-30       Impact factor: 10.121

8.  An Empirical Approach to Signature Peptide Choice for Selected Reaction Monitoring: Quantification of Uromodulin in Urine.

Authors:  Qin Fu; Eric Grote; Jie Zhu; Christine Jelinek; Anna Köttgen; Josef Coresh; Jennifer E Van Eyk
Journal:  Clin Chem       Date:  2015-11-20       Impact factor: 8.327

9.  Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma.

Authors:  Hannah Johnson; Forest M White
Journal:  J Proteome Res       Date:  2014-06-24       Impact factor: 4.466

Review 10.  The role of drug transporters in the kidney: lessons from tenofovir.

Authors:  Darren M Moss; Megan Neary; Andrew Owen
Journal:  Front Pharmacol       Date:  2014-11-11       Impact factor: 5.810

View more
  5 in total

1.  PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.

Authors:  Shannon M Jones; Adrien Mann; Kelsey Conrad; Keith Saum; David E Hall; Lisa M McKinney; Nathan Robbins; Joel Thompson; Abigail D Peairs; Eric Camerer; Katey J Rayner; Michael Tranter; Nigel Mackman; A Phillip Owens
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-29       Impact factor: 8.311

2.  A simple method for sphingolipid analysis of tissues embedded in optimal cutting temperature compound.

Authors:  Timothy D Rohrbach; April E Boyd; Pamela J Grizzard; Sarah Spiegel; Jeremy Allegood; Santiago Lima
Journal:  J Lipid Res       Date:  2020-04-27       Impact factor: 5.922

3.  Cryo-Gel embedding compound for renal biopsy biobanking.

Authors:  Malou L H Snijders; Marina Zajec; Laurens A J Walter; Remco M A A de Louw; Monique H A Oomen; Shazia Arshad; Thierry P P van den Bosch; Lennard J M Dekker; Michail Doukas; Theo M Luider; Peter H J Riegman; Folkert J van Kemenade; Marian C Clahsen-van Groningen
Journal:  Sci Rep       Date:  2019-10-24       Impact factor: 4.379

4.  Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma.

Authors:  Xin Xu; Ting Wei; Weijie Zhong; Rosalind Ang; Ye Lei; Hui Zhang; Qingshan Li
Journal:  Cancer Cell Int       Date:  2021-04-07       Impact factor: 5.722

5.  Spatially resolved metabolomic characterization of muscle invasive bladder cancer by mass spectrometry imaging.

Authors:  Anqi Tu; Neveen Said; David C Muddiman
Journal:  Metabolomics       Date:  2021-07-21       Impact factor: 4.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.